These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 22491688)
1. Prospective screening of novel antibacterial inhibitors of dihydrofolate reductase for mutational resistance. Frey KM; Viswanathan K; Wright DL; Anderson AC Antimicrob Agents Chemother; 2012 Jul; 56(7):3556-62. PubMed ID: 22491688 [TBL] [Abstract][Full Text] [Related]
2. Towards the understanding of resistance mechanisms in clinically isolated trimethoprim-resistant, methicillin-resistant Staphylococcus aureus dihydrofolate reductase. Frey KM; Lombardo MN; Wright DL; Anderson AC J Struct Biol; 2010 Apr; 170(1):93-7. PubMed ID: 20026215 [TBL] [Abstract][Full Text] [Related]
3. Crystal structures of wild-type and mutant methicillin-resistant Staphylococcus aureus dihydrofolate reductase reveal an alternate conformation of NADPH that may be linked to trimethoprim resistance. Frey KM; Liu J; Lombardo MN; Bolstad DB; Wright DL; Anderson AC J Mol Biol; 2009 Apr; 387(5):1298-308. PubMed ID: 19249312 [TBL] [Abstract][Full Text] [Related]
9. Sequence-specific 1H, 13C and 15N assignment of the TMP-resistant dihydrofolate reductase mutant DHFR(F98Y) in the ternary complex with TMP and NADPH. Altmann S; Labhardt AM; Senn H; Wüthrich K J Biomol NMR; 1997 Jun; 9(4):445-6. PubMed ID: 9255948 [No Abstract] [Full Text] [Related]
10. Crystal Structures of Trimethoprim-Resistant DfrA1 Rationalize Potent Inhibition by Propargyl-Linked Antifolates. Lombardo MN; G-Dayanandan N; Wright DL; Anderson AC ACS Infect Dis; 2016 Feb; 2(2):149-56. PubMed ID: 27624966 [TBL] [Abstract][Full Text] [Related]
11. Resistance to antibacterial antifolates in multidrug-resistant Staphylococcus aureus: prevalence estimates and genetic basis. Kime L; Waring T; Mohamad M; Mann BF; O'Neill AJ J Antimicrob Chemother; 2023 May; 78(5):1201-1210. PubMed ID: 36935372 [TBL] [Abstract][Full Text] [Related]
12. In vitro efficacy of new antifolates against trimethoprim-resistant Bacillus anthracis. Barrow EW; Dreier J; Reinelt S; Bourne PC; Barrow WW Antimicrob Agents Chemother; 2007 Dec; 51(12):4447-52. PubMed ID: 17875993 [TBL] [Abstract][Full Text] [Related]
13. A trimethoprim derivative impedes antibiotic resistance evolution. Manna MS; Tamer YT; Gaszek I; Poulides N; Ahmed A; Wang X; Toprak FCR; Woodard DR; Koh AY; Williams NS; Borek D; Atilgan AR; Hulleman JD; Atilgan C; Tambar U; Toprak E Nat Commun; 2021 May; 12(1):2949. PubMed ID: 34011959 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory properties and X-ray crystallographic study of the binding of AR-101, AR-102 and iclaprim in ternary complexes with NADPH and dihydrofolate reductase from Staphylococcus aureus. Oefner C; Parisi S; Schulz H; Lociuro S; Dale GE Acta Crystallogr D Biol Crystallogr; 2009 Aug; 65(Pt 8):751-7. PubMed ID: 19622858 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of Resistance to Folate Pathway Inhibitors in Podnecky NL; Rhodes KA; Mima T; Drew HR; Chirakul S; Wuthiekanun V; Schupp JM; Sarovich DS; Currie BJ; Keim P; Schweizer HP mBio; 2017 Sep; 8(5):. PubMed ID: 28874476 [TBL] [Abstract][Full Text] [Related]
16. Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity. Oefner C; Bandera M; Haldimann A; Laue H; Schulz H; Mukhija S; Parisi S; Weiss L; Lociuro S; Dale GE J Antimicrob Chemother; 2009 Apr; 63(4):687-98. PubMed ID: 19211577 [TBL] [Abstract][Full Text] [Related]
17. Cloning and characterization of a novel trimethoprim-resistant dihydrofolate reductase from a nosocomial isolate of Staphylococcus aureus CM.S2 (IMCJ1454). Sekiguchi J; Tharavichitkul P; Miyoshi-Akiyama T; Chupia V; Fujino T; Araake M; Irie A; Morita K; Kuratsuji T; Kirikae T Antimicrob Agents Chemother; 2005 Sep; 49(9):3948-51. PubMed ID: 16127079 [TBL] [Abstract][Full Text] [Related]
18. Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim. Heaslet H; Harris M; Fahnoe K; Sarver R; Putz H; Chang J; Subramanyam C; Barreiro G; Miller JR Proteins; 2009 Aug; 76(3):706-17. PubMed ID: 19280600 [TBL] [Abstract][Full Text] [Related]
19. Iclaprim, a novel diaminopyrimidine with potent activity on trimethoprim sensitive and resistant bacteria. Schneider P; Hawser S; Islam K Bioorg Med Chem Lett; 2003 Dec; 13(23):4217-21. PubMed ID: 14623005 [TBL] [Abstract][Full Text] [Related]
20. Structure-guided functional studies of plasmid-encoded dihydrofolate reductases reveal a common mechanism of trimethoprim resistance in Gram-negative pathogens. Krucinska J; Lombardo MN; Erlandsen H; Estrada A; Si D; Viswanathan K; Wright DL Commun Biol; 2022 May; 5(1):459. PubMed ID: 35562546 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]